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Introduction 
In March 2020 the World Health Organization 
(WHO) declared that the world was going through a 
pandemic, all because of the uncontrolled dissemination 
of the SARS-Cov-2 and this state is maintained until 
nowadays. Because of this reality, there was a huge 
change in priorities in the health field, making the 
COVID-19 infection the main focus and, consequently, 
diminishing the care of other pathologies, cancer being 
one of them [1]. Even in a scenario that strategies were 
adopted to reduce the COVID-19 transmission, as the 
need for social distancing, the patients kept receiving 
oncological diagnosis and reassuring the rising number 
of cases reported of this disease and its need for 
treatment [1].  
In view of these priorities changes in health care 
and the number of cancer diagnoses, the need to 
analyse the correlation between the COVID-19 infection 
in oncology patients and its influence over their 
treatment arose. Oncology patients have their immune 
system compromised in different degrees, these 
compromises are developed from neoplasms and 
therapeutic interventions, according to each case. When 
infected, adults with cancer are classified as a risk 
group, besides being more likely to develop worst cases 
and prognosis [2]. However, paediatric cancer patients 
with the COVID-19 infection, despite few scientific 
studies, are less likely to have worst case scenarios and 
morbidity when compared to non oncologic paediatric 
groups [2]. 
It is also important to highlight that there is a need 
to relocate patients to reference centers, where the 
treatment can be continued in the best way possible, 
and because of this, it became necessary to adapt the 
care provided by oncology health institutions and means 
of transportation, so that they are able to provide 
patients and their families with the best service care 
while following all security protocols needed to avoid 
infection and propagation of these viruses [3].  
The aim of this review is to study the influence that 
the Sars-CoV-2 pandemic had over the therapeutic 
oncology care, to determine which methods were 
developed to dim their interference over the oncology 
treatment and to investigate if there still is influence 
over their therapeutic developments. 
 
Methods 
This is a systematic literature review based on the 
following questions: 1. Did the COVID-19 pandemic 
have influence over the treatment of oncological 
patients? 2. Which measures were settled to attenuate 
the COVID-19 influence over the oncological treatment?  
3. How the relation between COVID-19 and oncological 
treatment was determined? Is there any interference on 
the treatment response?  The articles selected to the 
study had to meet the following eligibility criteria: (1) be 
published in national or international journals; (2) be 
published between 2020 and 2021; (3) be fully available 
for free. Were excluded from this study those articles 
which did not answer the scientific questions proposed 
by the research team. The bibliographic research was 
carried out in Google Scholar, Mendeley, PubMed and 
Scielo databases during June to August 2021. 
Descriptors used are “COVID-19,” “Oncological 
treatment,” “Cancer,” and “Oncology". At the first stages 
for the article selection, all duplicates were removed and 
the research team tracked their titles. Secondly, the 
eligible articles abstracts were used to execute a triage 
of the full texts. After that, the team members extracted 
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form, which includes information about the study 
characteristics (title, year and country of origin), 
methodology and the answer of the scientific questions 
proposed. 
 
Results and Discussion 
A list of 71 articles was found in the search 
databases, being found n = 19 in Google Scholar, n=20 
in Mendeley, n = 18 in PubMed and n=14 in Scielo 
platforms. Of articles that were eligible, n=17 were 
found in Google Scholar, n=7 were found in Mendeley, 
n=14 were found in PubMed and n=9 were found in 
Scielo platforms. The systematic literature review 
consists of 47 articles. The other 24 studies were found 
not eligible. The psychosocial impacts of the cancer 
diagnoses are extremely difficult to manage, and in the 
pandemic context and social isolation it became more 
evident [4]. After all, it is a fact that the oncologic 
patient is particularly more susceptible to the morbidities 
and mortality [5]. Such effect can be explained by 
different points: the immunocompromised and higher 
risk of infection of cancer patients; the evasion of 
medical appointments and therapeutic follow-ups; the 
late cancer diagnosis due to its clinical similarities to 
COVID-19; the adaptations made by the health 
institutions that provided service during the virus 
outbreak; the lack of universal protocols to the care of 
oncological patients. Against these fragility, the increase 
in the evasion of oncologic therapeutic appointments 
was justified by the patient’s fear of presenting the 
worst SARS-Cov-2 clinical manifestations [6,7]. 
However, some patients that do opt to attend to their 
therapies are welcomed with poor services - slow 
access, regulations and diagnosis [8].  
Moreover, in a medical appointment, when the 
professional identifies some common cancer signs or 
even some toxic effects of the oncological therapy, 
those can be mistaken for common SARS-CoV-2 
symptoms [5]. Thereafter, it results in postponement of 
the tracking, late diagnosis  and even worst prognosis 
[9,10]. When talking about therapeutic measures, there 
is not a specific therapy that acts against the COVID-19 
infection and offers beneficial survival results to patients 
with cancer, beyond that, some oncological 
interventions can be subjected to postponement [5,11].   
In other words, the pandemic scenario has brought 
a negative impact over the oncological field. There is a 
need to correctly guide the patient and it could only be 
truly accomplished with multidisciplinary collaboration, 
being also necessary the elaboration of acting plans and 
guidelines to the standardization of the health care [12].  
As the virus spreads, it is undeniable the need to study 
the relations between cancer and SARS-CoV-2, in order 
to optimise the care and decrease the therapeutic 
interruptions [13]. Likewise, the COVID-19 outbreak has 
been severely paralysing researches and possibly 
delaying beneficial findings to the fight against cancer 
[13]. Therefore, it is apparent how much this current 
situation will continue to affect cancer patients care, 
whereas the COVID-19 priority comes postponing the 
perspective of success in the field of oncology. Against 
these uncertainty scenarios due to the Sars-CoV-2 
pandemic it is undeniable that there is a need to deepen 
the studies aiming to define strategies that help with the 
diagnosis, caring and treatment specific for each case, 
mostly when it involves oncologic patients [14], because 
these compose an at-risk group for serious covid-19 
infections outcome, especially as a result of their 
immune deficiency state [2]. 
 
Conclusion 
It is needed to deeply analyze the relation between 
the oncological therapy and the Sars-CoV-2 infection to 
determine if there are interferences and/ or losses in the 
cancer treatment, and to indicate which measures 
should be adopted to minimize those interferences and 
losses. It is at most urgency that guidelines and 
normatives are established to homogenize the 
oncological care in the health institutions during the 
duration of the Sars-CoV-2 pandemic, besides the 
creation of new protocols to guide the diagnosis and 
treatment of patients that went unnoticed during the 
virus outbreak. 
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